Innovations in brain health are offering new hope for individuals recovering from brain traumas and addiction. Two promising ...

Sara Penuela Rodriguez (left), an interdisciplinary neuroscience doctoral student, administers infrared laser light therapy ...

LumiThera’s PBM is the only device that has demonstrated meaningful vision improvement compared to baseline for people living ...

A growing body of evidence suggests that using infrared light — photobiomodulation, as scientists call it — can spur cellular changes in the body that may reduce pain, improve skin, sleep and ...

Alcon to Acquire LumiThera and its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD) ...

Red-light therapy is getting the green light in some health circles, but it’s early yet to say whether that’s a good thing. The treatment, a type of light therapy called photobiomodulation ...

In the modern and fast-paced society, balancing work, family, and self-care can be quite an ordeal. Red light therapy (RLT) – ...

Red light therapy could help with common aches and pains, but researchers don’t yet know how or what makes a device effective.

Meeting Coverage > ASRS Photobiomodulation for Early Dry AMD Gets Enthusiastic Reception — Significant improvement in BCVA versus historical declines, 75% decrease in new-onset cases by Charles ...

LumiThera, Inc., a medical device company commercializing a photobiomodulation (PBM) treatment for ocular damage and disease, today announced a new Ca ...

This is a developing news story. Please check back soon for updates. Alcon will acquire LumiThera, including its ...

LumiThera’s photobiomodulation (PBM) device is the first and only technology that has demonstrated meaningful visual improvement with two years of treatments* in early and intermediate dry AMD ...